OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation
Junjun Ling, Yuhong Wang, Lihai Ma, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 11
Junjun Ling, Yuhong Wang, Lihai Ma, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 11
Showing 11 citing articles:
Shunli Feng, Wubin Yuan, Zhen Sun, et al.
Journal of Oral Pathology and Medicine (2022) Vol. 51, Iss. 7, pp. 620-629
Closed Access | Times Cited: 24
Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancer
Kavita Goyal, M. Arockia Babu, Muhammad Inam Afzal, et al.
Journal of Complementary and Integrative Medicine (2025)
Closed Access
Kavita Goyal, M. Arockia Babu, Muhammad Inam Afzal, et al.
Journal of Complementary and Integrative Medicine (2025)
Closed Access
Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date
Mengdi Liang, Yang Huang, Shengfeng Huang, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access
Mengdi Liang, Yang Huang, Shengfeng Huang, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access
Single-nucleus RNA sequencing and network pharmacology reveal the mediation of fisetin on neuroinflammation in Alzheimer's disease
Tingting Cao, Peiling Liao, Jia Lu, et al.
Phytomedicine (2025), pp. 156724-156724
Closed Access
Tingting Cao, Peiling Liao, Jia Lu, et al.
Phytomedicine (2025), pp. 156724-156724
Closed Access
Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation
Xingyun Liu, Ren Yanling, Shuanglin Qin, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Xingyun Liu, Ren Yanling, Shuanglin Qin, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
Sareshma Sudhesh Dev, Reyhaneh Farghadani, Syafiq Asnawi Zainal Abidin, et al.
Journal of Functional Foods (2023) Vol. 110, pp. 105845-105845
Open Access | Times Cited: 6
Sareshma Sudhesh Dev, Reyhaneh Farghadani, Syafiq Asnawi Zainal Abidin, et al.
Journal of Functional Foods (2023) Vol. 110, pp. 105845-105845
Open Access | Times Cited: 6
Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation
Tian Li, Junjun Ling, Xingrong Du, et al.
Nutrition & Metabolism (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Tian Li, Junjun Ling, Xingrong Du, et al.
Nutrition & Metabolism (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Improved low water solubility of fisetin by enzymatic encapsulation reaction using cycloamylose produced by cyclodextrin glucanotransferase
Hyun-Mo Jeong, Hae-Na Kang, Ye-Rim Lee, et al.
Process Biochemistry (2023) Vol. 130, pp. 138-146
Open Access | Times Cited: 5
Hyun-Mo Jeong, Hae-Na Kang, Ye-Rim Lee, et al.
Process Biochemistry (2023) Vol. 130, pp. 138-146
Open Access | Times Cited: 5
MYO1B as a prognostic biomarker and a therapeutic target in Arecoline‐associated oral carcinoma
Zhen Sun, Xiaopeng Guo, Huarong Chen, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 7, pp. 920-939
Closed Access | Times Cited: 4
Zhen Sun, Xiaopeng Guo, Huarong Chen, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 7, pp. 920-939
Closed Access | Times Cited: 4
Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
Junjun Ling, Yu Huang, Zhen Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Junjun Ling, Yu Huang, Zhen Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Exploring the therapeutic mechanisms of resveratrol for treating arecoline‐induced malignant transformation in oral epithelial cells: insights into hub targets
Zhen Sun, Xiaopeng Guo, Changya Li, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 13, pp. 8290-8305
Closed Access
Zhen Sun, Xiaopeng Guo, Changya Li, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 13, pp. 8290-8305
Closed Access
